FDA CLEARS NEW INDICATION FOR ACCUFUSER PUMP
The FDA has granted a premarket notification clearance to McKinley Medical allowing the company to market its Accufuser Post-Op Pain Control Pump for use in significantly decreasing the use of narcotic pain medications following surgery.
The device is a portable, non-electronic balloon infuser that delivers continuous infusion of local anesthetic through a special catheter to the site of the surgery. While wearing Accufuser, patients can press a bolus button to receive additional doses of non-narcotic medication to enhance their comfort. It is also made entirely of non-latex materials, allowing for the device to be lightweight enough so patients can use it anywhere they go following general, orthopedic, aesthetic/plastic and other surgical procedures.
This most recent FDA clearance follows three previous 510(k)s clearing McKinley Medical to market the Accufuser pump for postoperative pain management and regional anesthesia.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May